1.Study on Abdominal Sequelae after Free TRAM Flap or Rectus Abdominis Muscular Free Flap Operation.
Kyung Won MINN ; Sang Baek HAN ; Yoon Ho LEE ; Suk Wha KIM
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1999;26(2):257-262
The TRAM flap provides the safe creation of a durable, soft, natural-appearing breast mound and has thus become the most popular method of breast reconstruction. On the other hand, the rectus muscle can be used as a good donor site for a flap reconstruction in trauma or osteomyelitis cases on the lower extremity. The abdominal sequelae, including abdominal wall dysfunction after free rectus muscle transfer, was evaluated. Thirty-seven patients underwent free TRAM (n=29) or rectus abdominis muscular free flap(n = 8) operations between 1994 and 1997. In harvesting of the TRAM flap, a muscle-splitting technique was used and thus one-quarter of the muscle was preserved. In rectus muscular free flap, the entire width of the rectus abdominis muscle was harvested. Among the 37 patients, 26 patients (20 free TRAM flap and 6 rectus muscular free flap) were studied, for they were followed up postoperatively for at least 6 months and had provided preoperative data of abdominal strength. Cosmetic results of the abdomem were appraised by four independent judges on photographs taken of 26 patients. The global appearance of the abdomen was rated as "natural" in 75%. The scar on the umbilicus and lower abdomen was rated as acceptable or not visible in 65%. The replies to questionnaires were analyzed Patient self-assessment showed general satisfaction. In 24 of 26 answers, they said they would recommend the operation to others, and 70% of the patients found their abdominal strength and sports ability the same or improved. Thirty percent of the patients complained that back pain developed or became aggravated after surgery. Abdominal muscular strength was tested both preoperatively and 6 months to 1 year period after surgery according to Lacote. The abdominal wall function was impaired, especially in the upper rectus and external oblique muscle. In conclusion even though the abdominal sequelae after free TRAM or rectus muscular free flap reconstruction should not be urderestimated, no problem of clinical significance was encountered, and patients showed a high degree of satisfaction with the operation
Abdomen
;
Abdominal Wall
;
Back Pain
;
Breast
;
Cicatrix
;
Female
;
Free Tissue Flaps*
;
Hand
;
Humans
;
Lower Extremity
;
Mammaplasty
;
Osteomyelitis
;
Surveys and Questionnaires
;
Rectus Abdominis*
;
Self-Assessment
;
Sports
;
Tissue Donors
;
Umbilicus
2.Management for Obstructed Carcinoma of the Left Colon.
Hyun Chul KIM ; Moo Jun BAEK ; Nae Kyung PARK ; Moon Soo LEE ; Yong Suk JANG ; Ok Pyung SONG
Journal of the Korean Society of Coloproctology 1998;14(2):209-216
The management of malignant left colon obstruction remains a difficult problem. Conventional surgical treatment is muti-staged and each stage carries its own morbidity and mortality. The purpose of this study is to identify the feasibility and safety of one stage operation in patients presenting with acute obstruction of the left colon. From January 1991 to June 1996, 29 patients received one stage resection for acutely obstructed carcinoma of the left colon at Soonchunhyang University Chunan Hospital. Subtotal colectomies were performed in 9 patients(31.0%), left hemicolectomies in 6(20.7%), low anterior resection in 6(20.7%), sigmoid colectomy in 4(13.8%), anterior resection in 4 patients(13.8%). Subtotal colectomy was performed in patients with massively distended colon of dubious viability and to contain ischemic lesions at proximal colon. Total operative mortality was 6.9%: 5% in the immediate resection with anastomosis group, 11.1% in subtotal colectomy group. Complications included wound infection(4), fecal incontinence(2), intestinal obstruction(2), anastomotic leakage(1), upper G-I bleeding(1), postoperative bleeding(1), pulmonary complication(1). Our results suggest that resection and primary anastomosis can be performed with acceptable morbidity and mortality in patients with acute malignant obstruction of the left colon.
Chungcheongnam-do
;
Colectomy
;
Colon*
;
Colon, Sigmoid
;
Humans
;
Mortality
;
Wounds and Injuries
3.Facial skin graft using preauricular and forehead expansion.
Sang Baek HAN ; Chin Whan KIM ; Chul Gyoo PARK ; Yoon ho LEE ; Kyung Won MINN ; Suk Wha KIM
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1998;25(6):1147-1152
Skin graft has been widely used for facial skin reconstruction. Inguinal area is the common donor site for full-thickness skin graft of various area. Especially for facial skin graft, retroauricular area or upper eyelid skin has been used as a donor site. But these donor sites have some limitations as perfect ones in terms of size, color and texture when applied onto facial area. Even retroauricular skin shows color and texture differences from normal facial skin after it is grafted. Authors performed expansion of the skin of preauricular area or forehead where minimal scars would come out after final operation. We harvested this expanded skin and performed skin graft following excision of nevus, poor scar, or hemangioma in face.We achieved satisfactory results in terms of color and texture by applying this method in 11 clinical cases; 4 cases of hemangioma, 4 nevus, and 3 cases of traumatic scar. Donor site scars were clinically inspicuous in all these 11 cases.
Cicatrix
;
Eyelids
;
Forehead*
;
Hemangioma
;
Humans
;
Nevus
;
Skin*
;
Tissue Donors
;
Transplants*
4.THE EFFECTS OF A THIN SHEET OF TYPE I COLLAGEN ON WOUND HEALING OF FULL THICKNESS SKIN DEFECTS.
Eui Tae LEE ; Heung Sik PARK ; Won Suk HYUN ; Sang Baek HAN ; Suk Wha KIM ; Kyung Chan PARK ; Hwal SUH ; Saik BANG ; Albert K OH
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(6):1245-1252
No abstract available.
Collagen Type I*
;
Skin*
;
Wound Healing*
;
Wounds and Injuries*
5.Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion.
Tae Kyu LEE ; Jong Tae BAEK ; Suk Kyung LEE ; Sun Woo KIM ; Kee Won KIM ; Ji Won SUHR ; Suk Young PARK ; Kyung Shick LEE
Korean Journal of Medicine 1999;57(2):191-196
BACKGROUND: Maligant pleural effusions are common and significant problems in patient with advanced malignancies. In comparison with traditional sclerosing agent, intrapleural chemotherapy has a potential advantage of treating the underlying malignancy in addition to providing local control of th effusion. This study evaluated efficacy of intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion from lung cancer and others. METHODS: 29 patients with pathology-proven malignant pleural effusion were prospectively analyzed to estimate the effect of intrapleural chemotherapy. A single dose of cisplatin 100mg/m plus cytarabine 1200mg/m in the 250ml normal saline were instilled into the pleural space via a chest tube and drained 4 hours later. Patients were evaluated for toxicity and response at 24hours, 1st, 2nd, 3rd week, and monthly interval. No recurrence of the effusion was considered a complete response(CR). Partial responses (PR) was defined as a 75% or greater decrease in the amount of effusion on serial chest radiographs. RESULTS: The overall response rate(CR plus PR) was 93.1% (27 of 29 patients). The median length of response was 7.5 months. Among 17 patients who were assessable until they died, 14 patients(82%) maintained complete response at the last follow-up. One patient experienced reversible grade 4 myelosuppression, 3 patients had grade 3 nausea & vomiting. 2 patients had empyema, and 2 patients had wound infection. CONCLUSIONS: The outcome of this trial indicated that the intrapleural chemotherapy with cisplatin and cytarabine with little treatment related mortality and morbidity.
Chest Tubes
;
Cisplatin*
;
Cytarabine*
;
Drug Therapy*
;
Empyema
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms
;
Mortality
;
Nausea
;
Pleural Effusion
;
Pleural Effusion, Malignant*
;
Prospective Studies
;
Radiography, Thoracic
;
Recurrence
;
Vomiting
;
Wound Infection
6.A case of nephrogenic systemic fibrosis following gadolinium exposure in a peritoneal dialysis patient.
Tae Hyoung KOO ; Dong Hyun LEE ; Hee Kyung BAEK ; Do Kyong KIM ; Bo Kyung KIM ; Suk Hee HONG ; Won Suk AN
Korean Journal of Medicine 2010;78(4):507-511
Nephrogenic systemic fibrosis is a systemic illness that only affects patients with kidney failure. Exposure to gadolinium-based contrast agents has been associated with the subsequent development of nephrogenic systemic fibrosis in patients with decreased renal function. Nephrogenic systemic fibrosis is characterized by skin induration after swelling and limited joint movement through a loss in flexibility that preferentially affects the extremities. A 58-year-old man in peritoneal dialysis developed swelling and stiffness of the lower limbs following gadolinium exposure for brain magnetic resonance imaging. This patient was diagnosed with nephrogenic systemic fibrosis by CD34 immunoreactivity of subcutaneous fibroblasts in a skin biopsy. We report, for the first time in Korea, that nephrogenic systemic fibrosis developed after gadolinium exposure in a peritoneal dialysis patient.
Biopsy
;
Brain
;
Contrast Media
;
Extremities
;
Fibroblasts
;
Gadolinium
;
Humans
;
Joints
;
Korea
;
Lower Extremity
;
Magnetic Resonance Imaging
;
Middle Aged
;
Nephrogenic Fibrosing Dermopathy
;
Peritoneal Dialysis
;
Pliability
;
Renal Insufficiency
;
Skin
7.Evaluation for Patterns of the Maternal Weight changes and the Twin Weight Discordance Changes during whole Pregnant Periods.
Min Jung BAEK ; Kyung Ju LEE ; Suk Ho KANG ; Kyoung Jin LEE ; Sang Won PARK ; Won Bo HAHN
Korean Journal of Perinatology 2006;17(2):181-188
OBJECTIVES: To evaluate the patterns of changes in maternal weight and fetal weight discordance in twin pregnancies during consecutive gestational periods. METHODS: A retrospective chart review was done for a total of 148 twin pregnancies taken care of throughout pregnancies between February 2002 and May 2004. They were divided into two groups; group A consisting of 109 cases without postnatal complications and with no more than 25% twin weight discordance at birth, and group B consisting of 39 cases with more than 25% twin weight discordance. Both ultrasound examination and maternal weight measurement were conducted in the three gestational intervals; between prepregnant times to gestational age 18 weeks, between gestational ages 18 to 28 weeks, and from gestational age 28 weeks to delivery. RESULTS: Except for maternal weights, none of the pregnancy factors such as maternal age, parity, gravity, height, prepregnant weight, duration of pregnancy, natural or artificial pregnant status, gender and chorionicity showed any significant difference by means between the two groups. The maternal BMI of the group A vs. the group B at the first, the second, and the third period were 0.53+/-0.10% and 2.01+/-1.28%, 2.97+/-0.11% and 4.84+/-1.23%, and 3.29+/-0.16% and 2.15+/-0.63% respectively. Inter-twin weight discordances between the two groups were 8.29+/-0.67% vs. 11.26+/-1.25 %, 7.79+/-0.05% vs. 11.03+/-1.36%, and 9.07+/-0.55% vs. 32.79+/-1.13%, respectively. CONCLUSIONS: Although several factors that affect twin weight discordance may be considered, we showed that the pattern of maternal weight gain during the gestational period is associated with the estimated values of twin weight discordances in the first gestational period.
Chorion
;
Female
;
Fetal Weight
;
Gestational Age
;
Gravitation
;
Humans
;
Maternal Age
;
Parity
;
Parturition
;
Pregnancy
;
Pregnancy, Twin
;
Retrospective Studies
;
Twins*
;
Ultrasonography
;
Weight Gain
;
Weights and Measures
8.A Case Demonstrating a Percutaneous Closure Using the Amplatzer Duct Occluder for Paravalvular Leakage after Tricuspid Valve Replacement.
Young Hee HEO ; Soo Jin KIM ; Sang Yun LEE ; Jae Suk BAEK
Korean Circulation Journal 2013;43(4):273-276
There has been a dramatic increase in the number and type of procedures performed in the field of cardiac intervention in the past decade. Percutaneous intervention is becoming an increasingly recognized modality for the management of prosthetic paravalvular leakages (PVLs) in severely symptomatic non-surgical candidates. Herein, we report our experience of percutaneous closure using the Amplatzer duct occluder for a PVL in a patient who underwent tricuspid valve replacement.
Heart Valve Prosthesis
;
Humans
;
Septal Occluder Device
;
Tricuspid Valve
;
Tricuspid Valve Insufficiency
9.Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients.
Kyung Hyun CHO ; Dong Gu SHIN ; Suk Hwan BAEK ; Jae Ryong KIM
Experimental & Molecular Medicine 2009;41(2):67-76
Several parameters and risk factors were compared between Korean male myocardial infarction (MI) patients (n = 10) and angina pectoris (AP) patients (n = 17) to search unique biomarkers for myocardial infarction (MI) in lipoprotein level. Individual serum and lipoprotein fractions (VLDL, LDL, HDL2, HDL3) were isolated and analyzed by lipid and protein determination and enzyme assay. The MI group was found to have a 25 and 30% higher serum cholesterol and triacylglycerol (TG) level than the AP group, respectively, however, their body mass index (BMI), LDL-cholesterol (C), HDL-C, and glucose levels fell within the normal range. MI patients were found to have an approximately two-fold higher level of serum IL-6 and an 18% lower serum apoA-I level than that of the AP group. LDL and HDL2 fraction of the MI group were more enriched with TG than those of AP group. The increased TG was correlated well with the increased level of apoC-III in the same fraction. Cholesteryl ester transfer protein (CETP) activity and protein level were greatly increased in MI patients in the LDL and HDL3 fractions. MI patients showed more severely oxidized LDL fraction than patients in the AP group, as well as the weakest antioxidant ability of serum. Conclusively, MI patients were found to have unique serum and lipoprotein characteristics including increased IL-6 and TG in serum, with CETP and apoC-III in the LDL and HDL fractions, as well as severely impaired antioxidant ability of HDL.
Aged
;
Angina Pectoris/*blood
;
Apolipoprotein C-III/blood
;
Cholesterol Ester Transfer Proteins/blood
;
Copper/metabolism
;
Humans
;
Lipids/blood
;
Lipoproteins/*blood
;
Lipoproteins, LDL/blood
;
Male
;
Middle Aged
;
Myocardial Infarction/*blood
;
Oxidation-Reduction
;
Triglycerides/blood
10.Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients.
Kyung Hyun CHO ; Dong Gu SHIN ; Suk Hwan BAEK ; Jae Ryong KIM
Experimental & Molecular Medicine 2009;41(2):67-76
Several parameters and risk factors were compared between Korean male myocardial infarction (MI) patients (n = 10) and angina pectoris (AP) patients (n = 17) to search unique biomarkers for myocardial infarction (MI) in lipoprotein level. Individual serum and lipoprotein fractions (VLDL, LDL, HDL2, HDL3) were isolated and analyzed by lipid and protein determination and enzyme assay. The MI group was found to have a 25 and 30% higher serum cholesterol and triacylglycerol (TG) level than the AP group, respectively, however, their body mass index (BMI), LDL-cholesterol (C), HDL-C, and glucose levels fell within the normal range. MI patients were found to have an approximately two-fold higher level of serum IL-6 and an 18% lower serum apoA-I level than that of the AP group. LDL and HDL2 fraction of the MI group were more enriched with TG than those of AP group. The increased TG was correlated well with the increased level of apoC-III in the same fraction. Cholesteryl ester transfer protein (CETP) activity and protein level were greatly increased in MI patients in the LDL and HDL3 fractions. MI patients showed more severely oxidized LDL fraction than patients in the AP group, as well as the weakest antioxidant ability of serum. Conclusively, MI patients were found to have unique serum and lipoprotein characteristics including increased IL-6 and TG in serum, with CETP and apoC-III in the LDL and HDL fractions, as well as severely impaired antioxidant ability of HDL.
Aged
;
Angina Pectoris/*blood
;
Apolipoprotein C-III/blood
;
Cholesterol Ester Transfer Proteins/blood
;
Copper/metabolism
;
Humans
;
Lipids/blood
;
Lipoproteins/*blood
;
Lipoproteins, LDL/blood
;
Male
;
Middle Aged
;
Myocardial Infarction/*blood
;
Oxidation-Reduction
;
Triglycerides/blood